These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Autoantibodies to transducin in a patient with melanoma-associated retinopathy. Potter MJ, Adamus G, Szabo SM, Lee R, Mohaseb K, Behn D. Am J Ophthalmol; 2002 Jul; 134(1):128-30. PubMed ID: 12095824 [Abstract] [Full Text] [Related]
4. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy. Adamus G, Ren G, Weleber RG. BMC Ophthalmol; 2004 Jun 04; 4():5. PubMed ID: 15180904 [Abstract] [Full Text] [Related]
5. Incidence of antiretinal antibodies in melanoma: screening of 77 serum samples from 51 patients with American Joint Committee on Cancer stage I-IV. Ladewig G, Reinhold U, Thirkill CE, Kerber A, Tilgen W, Pföhler C. Br J Dermatol; 2005 May 04; 152(5):931-8. PubMed ID: 15888149 [Abstract] [Full Text] [Related]
8. Paraneoplastic vitelliform retinopathy: clinicopathologic correlation and review of the literature. Aronow ME, Adamus G, Abu-Asab M, Wang Y, Chan CC, Zakov ZN, Singh AD. Surv Ophthalmol; 2012 Nov 04; 57(6):558-64. PubMed ID: 22784677 [Abstract] [Full Text] [Related]
9. A case of melanoma-associated retinopathy with autoantibodies against TRPM1. Kim MS, Hong HK, Ko YJ, Park KH, Ueno S, Okado S, Woo SJ, Joo K. Doc Ophthalmol; 2020 Dec 04; 141(3):313-318. PubMed ID: 32472235 [Abstract] [Full Text] [Related]
10. Non-Paraneoplastic Autoimmune Retinopathy: The First Case Report in Korea. Choi EY, Kim M, Adamus G, Koh HJ, Lee SC. Yonsei Med J; 2016 Mar 04; 57(2):527-31. PubMed ID: 26847311 [Abstract] [Full Text] [Related]